肝母细胞瘤复发肩胛骨转移在FDG PET/CT与F-DOPA PET/CT上的显示
报告一例4岁女孩肝母细胞瘤及肝外转移切除并辅助化疗后生化复发(血浆甲胎蛋白57,987.6 μg/L),腹部超声、CT和MRI未能确定复发部位。FDG PET/CT示左侧肩胛骨及邻近软组织活性增高,被误判为术后修复或炎症改变;F-DOPA PET/CT示同一部位活性增高且病灶明显进展,最终病理证实左肩胛骨为肝母细胞瘤复发转移部位。
要点
- 肝母细胞瘤生化复发且常规影像未定位时,FDG PET/CT可显示左肩胛骨区活性增高。
- FDG PET/CT所示左肩胛骨区活性增高曾被误判为术后修复或炎症改变。
- F-DOPA PET/CT示同一部位活性增高且病灶进展,病理证实为肝母细胞瘤转移。
核心结论
- 病理检查最终证实左侧肩胛骨为肝母细胞瘤复发转移部位。
研究设计与样本
- 本文为病例报告,报告一例4岁女孩肝母细胞瘤及肝外转移切除并辅助化疗后生化复发的病例。
主要发现
- 患者血浆甲胎蛋白为57,987.6 μg/L。
- 腹部超声、CT和MRI未能确定复发部位。
- FDG PET/CT示左侧肩胛骨及邻近软组织区域活性增高,被误判为术后修复或炎症改变。
- F-DOPA PET/CT示同一部位活性增高且病灶明显进展。
- 病理检查证实左侧肩胛骨为肝母细胞瘤复发转移部位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the case of a 4-year-old girl with a biochemical relapse (plasma α-fetoprotein of 57,987.6 μg/L) after hepatoblastoma and extrahepatic metastases removal and adjuvant chemotherapy. Abdominal ultrasound, CT, and MRI failed to determine the site of recurrence. F-FDG PET/CT showed increased activity in the region of left scapula and adjacent soft tissue, which was incorrectly interpreted as the postoperative repair or inflammatory change. F-DOPA PET/CT showed increased activity and noticeable progressed lesion in the same place. Finally, the left scapula was identified as the site of recurrent metastasis from hepatoblastoma by pathological examination.
引用
- Zhang B, He Q, Shi X, et al. Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT. Clin Nucl Med. 2017. PMID: 28806258. doi:10.1097/RLU.0000000000001786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。